News Focus
News Focus
Replies to #68820 on Biotech Values
icon url

genisi

11/21/08 12:56 PM

#68846 RE: DewDiligence #68820

Just to note that Promacta is also being studied in phase III for thrombocytopenia associated with chronic HCV, chronic liver disease and oncology-related thrombocytopenia in phase I.